Subscribe to stay informed!
Castle Creek Pharmaceuticals in New Jersey has reached an agreement to acquire Fibrocell Science, the Exton-based biotechnology company, for $63.3 million, writes John…
Fibrocell Science in Exton is seeking approval from the FDA to start human testing of its experimental treatment for scleroderma, a rare autoimmune skin disorder…
Chester County Hero Fund
James Vito, who recently retired as Chester County’s chief county detective after logging 37 years in the District Attorney’s…
With a trio of potential solutions for rare skin diseases being studied or soon to be studied on humans, an Exton research firm took the…
After investing almost $3 million more cash in its operations, including $1 million more than the same quarter a year ago for gene therapy research…
The Wharton School alumnus and experienced chief financial officer Keith A. Goldan will stick around in Chester County in the wake of a major deal…
Kimberly M. Smith is new interim chief financial officer, treasurer and corporate secretary at Fibrocell Science, Inc.
David Pernock, Fibrocell’s chairman and CEO, thanked…
Its been a busy week for the people at Fibrocell, the Exton based autologous cell therapy company focused on developing first-in-class treatments for…
Institutional investors and equity analysts are invited to a research and development day in New York on Sept. 24 sponsored by Fibrocell Science of Exton…
In a move to attract investors, Fibrocell Science, Inc. of Exton is transferring its U.S. stock exchange listing from the New York Stock Exchange…
Fibrocell Science, Inc. of Exton, an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue…
Fibrocell Science, Inc. of Exton now has an exclusive license agreement with the regents of the University of California at Los Angeles to commercially apply…
What’s going on with Fibrocell Science’s (FCSC) shares?
According to Zacks Investment Research, the online research company, shares of the Exton based cell…
Exton based Fibrocell Science, Inc. recently reported its first quarter financials and what the company believes is a strong start for 2014.
The company, in…
Before we send you to this site, please subscribe to our daily newsletter.